Current Size: 100%
Age-specific survival
Cancer | Years | Method | Sex | Age | Survived | Net survival | 95% lower | 95% upper |
---|---|---|---|---|---|---|---|---|
Hodgkin | 2004-2008 | cohort | Female | 15-44 | 1.00 years | 98.6% | 96.6% | 100.0% |
Hodgkin | 2004-2008 | cohort | Female | 15-44 | 5.00 years | 95.1% | 91.6% | 98.8% |
Hodgkin | 2004-2008 | cohort | Female | 15-44 | 10.00 years | 93.5% | 89.3% | 97.9% |
Hodgkin | 2004-2008 | cohort | Female | 45-54 | 1.00 years | 100.0% | 0.0% | 0.0% |
Hodgkin | 2004-2008 | cohort | Female | 45-54 | 5.00 years | 82.1% | 63.0% | 100.0% |
Hodgkin | 2004-2008 | cohort | Female | 45-54 | 10.00 years | 82.1% | 63.0% | 100.0% |
Hodgkin | 2004-2008 | cohort | Female | 55-64 | 1.00 years | 84.4% | 71.4% | 99.8% |
Hodgkin | 2004-2008 | cohort | Female | 55-64 | 5.00 years | 76.8% | 61.9% | 95.2% |
Hodgkin | 2004-2008 | cohort | Female | 55-64 | 10.00 years | 61.7% | 41.2% | 92.2% |
Hodgkin | 2004-2008 | cohort | Female | 65-74 | 1.00 years | 84.5% | 70.7% | 100.0% |
Hodgkin | 2004-2008 | cohort | Female | 65-74 | 5.00 years | 60.1% | 42.0% | 86.2% |
Hodgkin | 2004-2008 | cohort | Female | 65-74 | 10.00 years | 41.1% | 23.0% | 73.4% |
Hodgkin | 2004-2008 | cohort | Female | 75-99 | 1.00 years | 50.4% | 33.9% | 74.8% |
Hodgkin | 2004-2008 | cohort | Female | 75-99 | 5.00 years | 38.5% | 20.8% | 71.2% |
Hodgkin | 2004-2008 | cohort | Female | 75-99 | 10.00 years | 26.3% | 10.3% | 67.2% |